These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2512324)

  • 1. Endotoxin removal by end-line filters.
    Vanhaecke E; De Muynck C; Remon JP; Colardyn F
    J Clin Microbiol; 1989 Dec; 27(12):2710-2. PubMed ID: 2512324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the endotoxin-retentive abilities of two '96-h' in-line intravenous filters.
    Richards C; Grassby PF
    J Clin Pharm Ther; 1994 Jun; 19(3):199-202. PubMed ID: 7962224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the endotoxin retention capabilities of inline intravenous filters.
    Horibe K; Mashima Y; Tashiro T; Yamamori H; Okui K
    JPEN J Parenter Enteral Nutr; 1990; 14(1):56-9. PubMed ID: 2109116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of endotoxin retentive intravenous filters with paediatric total parenteral nutrition solutions.
    Richards C; Thomas P
    J Clin Pharm Ther; 1990 Feb; 15(1):53-8. PubMed ID: 2108176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endotoxin removal by charge-modified filters.
    Gerba CP; Hou K
    Appl Environ Microbiol; 1985 Dec; 50(6):1375-7. PubMed ID: 3911902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial endotoxin retention by inline intravenous filters.
    Baumgartner TG; Schmidt GL; Thakker KM; Sitren HS; Cerda JJ; Mahaffey SM; Copeland EM
    Am J Hosp Pharm; 1986 Mar; 43(3):681-4. PubMed ID: 3518429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capture of latex beads, bacteria, endotoxin, and viruses by charge-modified filters.
    Hou K; Gerba CP; Goyal SM; Zerda KS
    Appl Environ Microbiol; 1980 Nov; 40(5):892-6. PubMed ID: 7004352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Filtration removal of endotoxin (pyrogens) in solution in different states of aggregation.
    Sweadner KJ; Forte M; Nelsen LL
    Appl Environ Microbiol; 1977 Oct; 34(4):382-5. PubMed ID: 335971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antibiotics and osmotic change on the release of endotoxin by bacteria retained on intravenous inline filters.
    Rusmin S; DeLuca PP
    Am J Hosp Pharm; 1975 Apr; 32(4):378-80. PubMed ID: 805534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic homology of endotoxin with a coliform mastitis vaccine strain, Escherichia coli O111:B4 (J5).
    Tyler JW; Spears H; Nelson R
    J Dairy Sci; 1992 Jul; 75(7):1821-5. PubMed ID: 1500577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depyrogenation of pharmaceutical solutions using submicron and ultrafilters.
    Brown S; Fuller AC
    J Parenter Sci Technol; 1993; 47(6):285-7. PubMed ID: 8120732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential hazards associated with microbial contamination of in-line filters during intravenous therapy.
    Holmes CJ; Kundsin RB; Ausman RK; Walter CW
    J Clin Microbiol; 1980 Dec; 12(6):725-31. PubMed ID: 6796597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubility of endotoxins from Escherichia coli and Pseudomonas aeruginosa.
    Eduard W; Westby MH; Larsson L
    Am J Ind Med; 2004 Oct; 46(4):375-7. PubMed ID: 15376280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Tris-acetate buffer on endotoxin removal from human-like collagen used biomaterials.
    Zhang H; Fan D; Deng J; Zhu C; Hui J; Ma X
    Mater Sci Eng C Mater Biol Appl; 2014 Sep; 42():124-9. PubMed ID: 25063101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partially-hydrophobized polymer particles derived from N,N-dimethylaminopropylacrylamide for endotoxin removal from acidic protein solution.
    Sakata M; Sueda T; Ihara H; Hirayama C
    Chem Pharm Bull (Tokyo); 1996 Feb; 44(2):328-32. PubMed ID: 8998839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Removal of endotoxin from antibody preparations for clinical use. Assessment of polymyxin-sepharose CNBr affinity chromatography.
    Lahiri VL; Srivastava RK; Hazra DK; Gupta AK; Painuly NK; Sharma SK; Khanna-Hazra P; Khanna P; Gupta RK; Pathak M
    Cell Biophys; 1994; 24-25():9-14. PubMed ID: 7736544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of different strategies for removal of endotoxins from bacteriophage preparations.
    Van Belleghem JD; Merabishvili M; Vergauwen B; Lavigne R; Vaneechoutte M
    J Microbiol Methods; 2017 Jan; 132():153-159. PubMed ID: 27913133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depyrogenation by endotoxin removal with positively charged depth filter cartridge.
    Hou KC; Zaniewski R
    J Parenter Sci Technol; 1990; 44(4):204-9. PubMed ID: 2213428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of sampling, extraction and preservation for the quantitation of biologically active endoto.
    Laitinen SK
    Ann Agric Environ Med; 1999; 6(1):33-38. PubMed ID: 10384213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of endotoxin-free bacteriophages.
    Boratyński J; Syper D; Weber-Dabrowska B; Łusiak-Szelachowska M; Poźniak G; Górski A
    Cell Mol Biol Lett; 2004; 9(2):253-9. PubMed ID: 15213806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.